Table 1.
Clinical and demographic characteristics of the study population
| Patient characteristics | |
|---|---|
| Total population | 146 patients |
| Male/female n, (%) | 89 (61)/57 (39) |
| Mean age (± SD) | 37.83 (± 14.4) |
| Mean BMI (± SD) | 24.0 (± 4.1) |
| Median age at the onset of disease (25–75 percentile) | 3 (1–13.2) |
| Atopic comorbidities | |
| Allergic rhinitis n, (%) | 50/146 (34.2) |
| Asthma n, (%) | 39/146 (26.7) |
| Allergic conjunctivitis n, (%) | 29/146 (23.3) |
| Chronic rhinosinusitis with nasal polyposis n, (%) | 1/146 (0.7) |
| Food allergy n, (%) | 15/146 (10.3) |
| Family history of atopic conditions including AD | 19/146 (13.0) |
| Previous treatments | |
| CsA n, (%) | 110/146 (75.3) |
| Dupilumab n, (%) | 136/146 (93.2) |
| Oral corticosteroids n, (%) | 62/146 (42.5) |
| Methotrexate n, (%) | 15/146 (10.3) |
| Phototherapy n, (%) | 11/146 (7.5) |
| Azathioprine n, (%) | 11/146 (7.5) |
| Tralokinumab n, (%) | 2/146 (1.7) |
AD atopic dermatitis, BMI body mass index, CsA cyclosporine, SD standard deviation